Vitamin D and Lupus (SLE)
Systemic lupus erythematosus (SLE) has a built-in vitamin D problem: patients are told to strictly avoid sun (photosensitivity triggers flares), which removes their main source of vitamin D. Rigorous sun avoidance plus sunscreen produces some of the lowest 25(OH)D levels seen in any chronic disease population.
Deficiency prevalence
Studies find mean 25(OH)D 15–20 ng/mL in SLE cohorts vs 25–30 in controls; 60–80% of SLE patients are deficient (< 20 ng/mL). The rate is even higher in Black lupus patients, whose already-lower baseline synthesis compounds with sun avoidance.
Disease activity link
Cross-sectional and longitudinal studies find inverse correlations between 25(OH)D and SLEDAI (SLE Disease Activity Index), anti-dsDNA antibody titres, and fatigue scores. The 2013 Australian Lupus Registry showed vitamin D-deficient patients had more flares and worse renal function over follow-up.
Supplementation trials
- Aranow 2015 — 100,000 IU weekly for 4 weeks then monthly; no effect on interferon signature.
- Abou-Raya 2013 — 2,000 IU/day for 12 months reduced fatigue and disease activity scores.
- Andreoli 2015 — repletion improved anti-dsDNA and complement levels in deficient patients.
- VITAL autoimmune substudy (2022) — 22% reduction in incident autoimmune disease with 2,000 IU/day in older adults.
Practical management
- All SLE patients should have 25(OH)D measured at diagnosis and yearly.
- Target ≥ 30 ng/mL, ideally 40–60.
- Standard dosing 2,000–4,000 IU/day; deficient patients often need loading regimens.
- Don't relax photoprotection — sun exposure is not an acceptable substitute for supplementation in lupus.
- Lupus nephritis patients: dose vitamin D under nephrology supervision, monitor calcium and PTH.